Published in Pharm Res on April 03, 2007
Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng Part A (2009) 2.12
Tunable self-assembly of genetically engineered silk--elastin-like protein polymers. Biomacromolecules (2011) 1.23
Applications of elastin-like polypeptides in tissue engineering. Adv Drug Deliv Rev (2010) 1.19
Cell response to RGD density in cross-linked artificial extracellular matrix protein films. Biomacromolecules (2008) 1.13
Smart self-assembled hybrid hydrogel biomaterials. Angew Chem Int Ed Engl (2012) 1.03
Surface Induced nanofiber growth by self-assembly of a silk-elastin-like protein polymer. Langmuir (2009) 0.98
Self-assembling peptide hydrogels modulate in vitro chondrogenesis of bovine bone marrow stromal cells. Tissue Eng Part A (2010) 0.97
Nanomechanical stimulus accelerates and directs the self-assembly of silk-elastin-like nanofibers. J Am Chem Soc (2011) 0.88
Elastomeric polypeptides. Top Curr Chem (2012) 0.85
Elastin-based biomaterials and mesenchymal stem cells. Biomater Sci (2015) 0.77
Resilin-PEG Hybrid Hydrogels Yield Degradable Elastomeric Scaffolds with Heterogeneous Microstructure. Biomacromolecules (2015) 0.77
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys (1961) 19.31
Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med (1994) 14.46
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69
In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res (1998) 8.24
Designing materials for biology and medicine. Nature (2004) 7.73
Tissue engineering--current challenges and expanding opportunities. Science (2002) 5.03
Reversible hydrogels from self-assembling artificial proteins. Science (1998) 3.71
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am (1994) 3.62
Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res (2002) 3.47
In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A (2002) 3.28
Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res (2001) 3.06
In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng (2003) 2.05
Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res (2000) 1.75
Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng (2006) 1.68
In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J Control Release (2004) 1.53
Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials (2006) 1.48
Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev (2002) 1.46
In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J Control Release (1998) 1.46
Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. In Vitro Cell Dev Biol Anim (2002) 1.38
Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. Biomaterials (2002) 1.36
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther (2001) 1.36
The potential for regeneration of articular cartilage in defects created by chondral shaving and subchondral abrasion. An experimental investigation in rabbits. J Bone Joint Surg Am (1991) 1.21
Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization. Mol Pharm (2005) 1.18
Genetically engineered polymers: status and prospects for controlled release. J Control Release (2004) 1.16
Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. J Control Release (2002) 1.13
Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm Res (2002) 1.11
Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N Y) (1991) 1.08
FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol Ther (2000) 1.06
Marrow stromal cells embedded in alginate for repair of osteochondral defects. Arthroscopy (2000) 1.04
Elastomeric polypentapeptides cross-linked into matrixes and fibers. Biomacromolecules (2001) 1.00
Biomaterials and scaffolds in reparative medicine. Ann N Y Acad Sci (2002) 0.94
Interaction of processes on different length scales in a bioelastomer capable of performing energy conversion. Biopolymers (2001) 0.92
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
Nanopattern-induced changes in morphology and motility of smooth muscle cells. Biomaterials (2005) 2.94
Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res (2007) 2.46
Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. J Nucl Med (2005) 2.09
Multifunctional nanorods for gene delivery. Nat Mater (2003) 2.09
Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials (2009) 1.97
Development of universal antidotes to control aptamer activity. Nat Med (2009) 1.93
Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules (2005) 1.86
Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol Ther (2008) 1.76
The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials (2007) 1.72
Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev (2006) 1.66
Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano (2011) 1.65
Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release (2006) 1.64
Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Ed Engl (2005) 1.61
In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J Control Release (2004) 1.53
Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One (2013) 1.52
Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling. Pharm Res (2006) 1.51
Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano (2011) 1.47
Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev (2002) 1.46
Aligned Protein-Polymer Composite Fibers Enhance Nerve Regeneration: A Potential Tissue-Engineering Platform. Adv Funct Mater (2007) 1.43
Significance of synthetic nanostructures in dictating cellular response. Nanomedicine (2005) 1.42
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials (2005) 1.42
Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials (2006) 1.41
Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine (2006) 1.38
Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol (2010) 1.38
Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem (2007) 1.36
Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. Biomaterials (2002) 1.36
Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials (2010) 1.33
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.31
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med (2011) 1.31
Complete recombinant silk-elastinlike protein-based tissue scaffold. Biomacromolecules (2010) 1.30
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials (2011) 1.30
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal (2013) 1.29
In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials (2007) 1.28
Cellular uptake and cytotoxicity of silica nanotubes. Nano Lett (2008) 1.27
Self-assembled supramolecular hydrogels formed by biodegradable PEO-PHB-PEO triblock copolymers and alpha-cyclodextrin for controlled drug delivery. Biomaterials (2006) 1.26
Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res (2007) 1.25
The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials (2004) 1.25
Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther (2007) 1.24
Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release (2002) 1.23
Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res (2004) 1.23
Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev (2005) 1.23
Electrohydrodynamics: A facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev (2009) 1.23
Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery. J R Soc Interface (2009) 1.22
Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol Pharm (2008) 1.21
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J Control Release (2012) 1.21
Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol Ther Nucleic Acids (2012) 1.20
Preparation and characterization of polypseudorotaxanes based on block-selected inclusion complexation between poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) triblock copolymers and alpha-cyclodextrin. J Am Chem Soc (2003) 1.20
Myogenic Induction of Aligned Mesenchymal Stem Cell Sheets by Culture on Thermally Responsive Electrospun Nanofibers. Adv Mater (2007) 1.20
Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des (2006) 1.20
Peripheral nerve regeneration by microbraided poly(L-lactide-co-glycolide) biodegradable polymer fibers. J Biomed Mater Res A (2004) 1.19
Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells. Biomaterials (2005) 1.19
MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn Reson Med (2005) 1.19
Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization. Mol Pharm (2005) 1.18
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology (2011) 1.17
Targeting tumor angiogenic vasculature using polymer-RGD conjugates. J Control Release (2005) 1.17
Nanotopography as modulator of human mesenchymal stem cell function. Biomaterials (2012) 1.16
Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine (2006) 1.16
Genetically engineered polymers: status and prospects for controlled release. J Control Release (2004) 1.16
Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. J Control Release (2009) 1.15
PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjug Chem (2006) 1.15
Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev (2012) 1.14
Recombinant silk-elastinlike protein polymer displays elasticity comparable to elastin. Biomacromolecules (2009) 1.13
Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. J Control Release (2005) 1.13
Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. J Control Release (2002) 1.13
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 1.12
Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials (2006) 1.11
Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm Res (2002) 1.11
Microfluidic synthesis of multifunctional Janus particles for biomedical applications. Lab Chip (2012) 1.10
Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin. J Biomed Mater Res A (2006) 1.10
Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy. Adv Drug Deliv Rev (2010) 1.10
Genetic engineering of stimuli-sensitive silkelastin-like protein block copolymers. Biomacromolecules (2003) 1.10
Viscoelastic behaviour of human mesenchymal stem cells. BMC Cell Biol (2008) 1.09
Interaction of human mesenchymal stem cells with disc cells: changes in extracellular matrix biosynthesis. Spine (Phila Pa 1976) (2006) 1.09
Label-free, high-throughput measurements of dynamic changes in cell nuclei using angle-resolved low coherence interferometry. Biophys J (2008) 1.09
Dual-sensitive micellar nanoparticles regulate DNA unpacking and enhance gene-delivery efficiency. Adv Mater (2010) 1.07
Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials (2005) 1.07
Rapid formation of multicellular spheroids in double-emulsion droplets with controllable microenvironment. Sci Rep (2013) 1.07
Engineering strategies to enhance nanoparticle-mediated oral delivery. J Biomater Sci Polym Ed (2008) 1.06
Wet-spinning of recombinant silk-elastin-like protein polymer fibers with high tensile strength and high deformability. Biomacromolecules (2009) 1.06
Polymeric conjugates for drug delivery. Chem Mater (2012) 1.06
Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and alpha-cyclodextrin. J Biomed Mater Res A (2003) 1.05
Nucleic acid scavengers inhibit thrombosis without increasing bleeding. Proc Natl Acad Sci U S A (2012) 1.05
Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. Nano Today (2012) 1.05
Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia. Pharm Res (2010) 1.04
Effect of Electromechanical Stimulation on the Maturation of Myotubes on Aligned Electrospun Fibers. Cell Mol Bioeng (2008) 1.04
Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials (2003) 1.04
Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting. J Control Release (2006) 1.04
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther (2002) 1.04
Quantum dot-based theranostics. Nanoscale (2009) 1.03
Controlled release from fibers of polyelectrolyte complexes. J Control Release (2005) 1.02